See More StocksHome

MS

Morgan Stanley

Show Trading View Graph

Mentions (24Hr)

6

200.00% Today

Reddit Posts

r/investingSee Post

Time required to liquidate an annuity?

r/pennystocksSee Post

Li-FT Power Intersects 23m at 1.40% Li2O at its Fi Main pegmatite, Yellowknife Lithium Project, NWT

r/optionsSee Post

Finance Stocks

r/pennystocksSee Post

$AGEN: AGENUS Stellar results presented

r/pennystocksSee Post

LIFT Intersects 27 m at 1.26% Li2O and 22 m at 1.53% Li2O at its Fi Main pegmatite, Yellowknife Lithium Project, NWT (TSXV: LIFT, OTCQX: LIFFF)

r/wallstreetbetsSee Post

2 Catalysts to load up on $MU - Microsoft boosts minimum PC RAM Specs to 16GB and North Korea backing out of Samsung collaboration for DRAM

r/WallStreetbetsELITESee Post

LIFT Intersects 23 m at 1.50% Li2O at its Fi Southwest pegmatite, Yellowknife Lithium Project, NWT (TSXV: LIFT, OTCQX: LIFFF)

r/wallstreetbetsSee Post

And so it begins, the 4 horsemen of the financial crisis $GS $BCS $MS $PNC

r/optionsSee Post

MS going 📉

r/pennystocksSee Post

LIFT Intersects 23 m at 1.50% Li2O at its Fi Southwest pegmatite, Yellowknife Lithium Project, NWT (TSXV: LIFT, OTCQX: LIFFF)

r/wallstreetbetsSee Post

$COIN / Bitcoin ratio is stupid. Long BTC short $COIN

r/investingSee Post

NervGen (NGEN.v and NGENF OTC) further signs their Paralysis Drug working in Human Trial, up 14%, then 13%, then 14%, then 34% and then 6% in last 5 days on heavy volume. Cured crushed spinal cords in animal trails and also MS and Stroke in animal trials, allows neurons to grow and reconnect.

r/pennystocksSee Post

LIFT Intersects 28 m at 0.99% Li2O at its BIG East pegmatite, Yellowknife Lithium Project, NWT (TSXV: LIFT, OTCQX: LIFFF)

r/WallStreetbetsELITESee Post

Inebriation Remedy And Breakthrough MS Treatment: Meet FSD Pharma - FSD Pharma (NASDAQ:HUGE)

r/pennystocksSee Post

LIFT Intersects 21 m at 1.12% Li2O at the Ki pegmatite, including 11 m at 1.70% Li2O and 17 m at 1.28% Li2O at the Shorty pegmatite, Yellowknife Lithium Project, NWT (TSXV: LIFT, OTCQX: LIFFF, FRA : WS0)

r/pennystocksSee Post

LIFT Intersects 28 m at 1.70% Li2O at its BIG East pegmatite, Yellowknife Lithium Project, NWT (TSXV: LIFT, OTCQX: LIFFF)

r/wallstreetbetsSee Post

I'm a professional regard and these are my notes 19/12

r/WallStreetbetsELITESee Post

Iceland Exploration Yields Bonanza Gold Grades Discovery Prompting the Spin-Out of Icelandic Holdings (CSE:SX)(OTCQB:SXOOF)(FSE:85G1)

r/pennystocksSee Post

LIFT Intersects 14 m at 1.50% Li2O at the Ki pegmatite and 10 m at 1.75% Li2O at the Shorty pegmatite, Yellowknife Lithium Project, NWT (CSE : LIFT, OTCQX: LIFFF, FRA : WS0)

r/smallstreetbetsSee Post

LIFT Intersects 14 m at 1.50% Li2O at the Ki pegmatite and 10 m at 1.75% Li2O at the Shorty pegmatite, Yellowknife Lithium Project, NWT (CSE : LIFT, OTCQX: LIFFF, FRA : WS0)

r/wallstreetbetsSee Post

Tgtx… been holding from $7-35-15~

r/stocksSee Post

Alibaba dips on MS downgrade as PDD grabs spot of most valuable Chinese e-commerce firm

r/pennystocksSee Post

👀 Woah! $SNPX. Might have found a totally under the radar goldmine. $SNPX is ~8x+ on cash alone. Low float of ~10m. Huge unmet need for Alzheimers advanced patients. AD positive data released in September. MS phase 1 expected by end of year. AD patent approval last week (largely unreported).

r/smallstreetbetsSee Post

LIFT Intersects 22 m at 1.35% Li2O and 22 m at 0.82% Li2O including 10 m at 1.35% at the BIG East pegmatite, Yellowknife Lithium Project, NWT (CSE : LIFT, OTCQX: LIFFF, FRA : WS0)

r/pennystocksSee Post

LIFT Intersects 22 m at 1.35% Li2O and 22 m at 0.82% Li2O including 10 m at 1.35% at the BIG East pegmatite, Yellowknife Lithium Project, NWT (CSE : LIFT, OTCQX: LIFFF, FRA : WS0)

r/wallstreetbetsSee Post

Altman, Brockman join MS

r/StockMarketSee Post

Research notes from Bulge Bracket analysts

r/pennystocksSee Post

$ATRA Long with Phase 2 Results Early Nov

r/smallstreetbetsSee Post

Stock dividend in the works for shareholders of FSD Pharma $HUGE. Their UNBUZZD product is being dividended out via its deal with Celly Nu

r/WallStreetbetsELITESee Post

Insights into $HSDT?

r/wallstreetbetsSee Post

FSD Pharma announces Interim Results from First-in-Human Clinical Trial of Lucid-MS (Lucid-21-302) for Multiple Sclerosis

r/WallStreetbetsELITESee Post

FSD Pharma announces Interim Results from First-in-Human Clinical Trial of Lucid-MS (Lucid-21-302) for Multiple Sclerosis; The Report Shows Compound to be Safe and Well Tolerated

r/investingSee Post

What kind of broker do billionaires use?

r/stocksSee Post

Is NVDA over or undervalued? MS updates price target today from $500 to $650, notes "remarkable growth" and massive "unmet demand."

r/WallStreetbetsELITESee Post

FSD Pharma Breaks Ground with Lucid-MS: A Glimpse into the Future of Multiple Sclerosis Treatment - US Business News

r/investingSee Post

Morgan Stanley Vs Fidelity

r/StockMarketSee Post

Microsoft SASE Questions

r/optionsSee Post

A Time Traveler's strategy (Final). Reinvestment of profits according to the Kelly criterion.

r/pennystocksSee Post

Dolly Varden Adds 5th Rig After Early Success with 2023 Drill Program

r/stocksSee Post

eTRADE => Morgan Stanley ( MS)

r/smallstreetbetsSee Post

Been liking Helius Med Tech recently

r/smallstreetbetsSee Post

VolSignals Recap 3 -> What IF the SPX "gamma-dam" breaks? 👀 US & GS on Flows 🌊

r/wallstreetbetsOGsSee Post

VolSignals Recap 3 -> What IF the SPX "gamma-dam" breaks? 👀 US & GS on Flows 🌊

r/wallstreetbetsSee Post

[Newbie] Bought Microsoft shares at 250 mainly as see value in ChatGPT. I think I'll hold for at least +6 months but I'd like your thoughts.

r/wallstreetbetsSee Post

$tgtx

r/WallstreetbetsnewSee Post

TGTX- TG THERAPEUTICS

r/StockMarketSee Post

Stock Market analysis [SURVEY on MS forms]

r/pennystocksSee Post

Grid Metals: Starts Drilling at Campus Creek, Buys Out Joint Venture Partner Option

r/pennystocksSee Post

Cerrado Gold Close to Securing Major Project Finance Loan

r/investingSee Post

Insider Trading: Only 13 companies among the top 100 traded in the US have more buy than sell transactions in the year so far

r/investingSee Post

Thoughts on JPM and Bank of america

r/wallstreetbetsSee Post

Market Recap - 6/15/23 - 🚀🚀🚀

r/wallstreetbetsSee Post

Market Recap - 6/5/23 - She had to sell everything

r/stocksSee Post

What are the best stocks that have less market cap than the 184B that NVDA jumped in one day?

r/weedstocksSee Post

Cannabis oral spray nabiximols found to ease spasticity in MS |...

r/pennystocksSee Post

An in-depth research into Glory Star New Media ($GSMG)

r/investingSee Post

Would you be squeamish buying a high rate CD from a bank you've never heard of? (Or should I be?

r/wallstreetbetsSee Post

Market Recap - 5/16/23 - schizophrenic trade continues

r/WallStreetbetsELITESee Post

FSD Pharma Completes Dosing of First Cohort in Phase I Clinical Trial of Lucid-MS, a New Drug Candidate for the Treatment of Multiple Sclerosis: Safety Review Committee Recommends Commencing Dosing of Second Cohort. $HUGE

r/smallstreetbetsSee Post

LEAPs on banking/financial services stocks

r/optionsSee Post

LEAPs on banking/financial services stocks

r/wallstreetbetsSee Post

Morgan Stanley is a predatory scam on the unsophisticated.

r/wallstreetbetsSee Post

$AAPL Today: Finanical Report

r/WallStreetbetsELITESee Post

Zoom likely to see 'little impact' if Microsoft decouples Teams from Office: MS

r/pennystocksSee Post

Stria Lithium reports best result to date, winter drilling at Pontax Property

r/wallstreetbetsSee Post

Suggest a Large Cap US hot stock for a minimum of 50% growth ..

r/wallstreetbetsSee Post

Track How U.S. Banks Are Faring in First-Quarter Earnings: How is anyone investing in Morgan Stanley!

r/pennystocksSee Post

Tiziana Life Sciences $TLSA is Bracing for an Explosive 2023

r/ShortsqueezeSee Post

CLNN- 6 Analyst have issued ratings the past mo (since release of updated Phase 2 MS & ALS data). All 6 rated Buy & all issued TP $7-15. CLNN is Currently $1.10 (MC of 85M). Over 2M Shorts & Vol past 10 days has been <250K. Rebound squeeze to 5+ as it jumps on more ppl radar.

r/investingSee Post

Morgan Stanley and Peloton

r/ShortsqueezeSee Post

CLNN is about to kick into gear.. 6 Analyst ratings the past mo (since release of updated Phase 2 MS & ALS data). All 6 rated Buy & PTs $7-15 (MC of 500M or 1B). CLNN is Currently $1.10 (MC of 85M). Over 2M Shorts & Vol past 10 days has been <250K. Rebound squeeze to 5+ as it jumps on >ppl radar

r/StockMarketSee Post

MARA & CLNN ... Rebound Squeeze Plays. Many are familiar with MARA. From a % standpoint, CLNN may provide an even larger rebound Squeeze:

r/ShortsqueezeSee Post

MARA & CLNN ... Rebound Squeeze Plays. Many are familiar with MARA. From a % standpoint, CLNN may provide an even larger rebound Squeeze:

r/ShortsqueezeSee Post

MARA & CLNN ... Rebound Squeeze Plays. Many are familiar with MARA. From a % standpoint, CLNN may provide an even larger rebound Squeeze:

r/pennystocksSee Post

$HUGE Financial report sparked a recent rally..looking for a $2 break here…

r/WallstreetbetsnewSee Post

The Catalysts Behind Tiziana Life Sciences' (NASDAQ: TLSA) 70%

r/wallstreetbetsSee Post

MSFT is back. And He is King.

r/pennystocksSee Post

The big disconnect between CLNN's current market cap & new price targets issued the past several weeks after new Phase 2 trial result updates.

r/stocksSee Post

What would you do in my position?

r/pennystocksSee Post

Grid Metals: High-Grade Lithium, Cesium & Tantalum Drill Core Assays

r/pennystocksSee Post

Stria Lithium Reports Positive Assay Results at Pontax-Central

r/pennystocksSee Post

Tiziana Life Sciences $TLSA is rising from the dead

r/wallstreetbetsSee Post

Stocks falling 'imminent' as investors realize earnings guidance looks unrealistic - MS By Investing.com

r/wallstreetbetsSee Post

Market Recap | Stocks Edge Higher as Pressure on Banks Continues

r/wallstreetbetsSee Post

History of Adobe stock?

r/wallstreetbetsSee Post

Thoughts on future of tech stocks?

r/wallstreetbetsSee Post

What is this candlestick?

r/wallstreetbetsSee Post

How does one know if big banks are abusing the new gov't bank liquidity loans?

r/wallstreetbetsSee Post

Microsoft Stock going up but PUT option premium also keep going up !! Any idea ?

r/stocksSee Post

Credit Suisse. What were some major negative developments over the last 10-20 years that made it lag so badly?

r/wallstreetbetsSee Post

MS-backed ChatGPT-4 debuts; Google-backed Claude releases to business customers; MS to integrate AI into office

r/stocksSee Post

MSFT Acquisition of ATVI

r/ShortsqueezeSee Post

CLNN is around $1.30 ... and Price targets of $13 and $15 were issued in the past 24 hours after positive Phase 2 MS results.

r/StockMarketSee Post

TLSA not TSLA

r/WallStreetbetsELITESee Post

S&amp;P 500 could rally to 4,150 if dollar and rates continue to fall - MS By Investing.com

r/wallstreetbetsSee Post

S&P 500 could rally to 4,150 if dollar and rates continue to fall - MS By Investing.com

r/StockMarketSee Post

Help creating Matlab code for Nickel Price forecasting using Geometric Brownian Motion and HWV Models

r/wallstreetbetsSee Post

Update to my technical analysis I posted here on 2/10 (Created in MS Paint this time)

r/wallstreetbetsSee Post

Visual representation of MS saying bull’s playtime is over (original poster at bottom of image)

r/wallstreetbetsSee Post

S&P 500 rally is a bull trap; bear market will resume in March - MS By Investing.com

Mentions

MS in Finance and CFA, completely worthless for trading stocks tbh

Mentions:#MS#CFA

Thanks I’m nearly done with an MS in Finance and you about threw me into an existential crisis haha.

Mentions:#MS

MS is a terrible disease. I would never wish that on a fellow regard.

Mentions:#MS

Serious question, does anyone here have an MS in Economics or Finance? Or are we all just regards who spout random funny shit.

Mentions:#MS

why!? They just secured a contract with MS.

Mentions:#MS

Ya he knew about the deal with MS in advance.

Mentions:#MS

That NBIS dude who noughts tons of shares on margin? Likely insider. People can be regarded but no one has that kinda courage to ruin their life on margin unless they knew about the MS deal.

Mentions:#NBIS#MS

Great DD, seriously well put together. You nailed the short term setup with insiders buying, institutional accumulation, and the ECTRIMS late breaker catalyst. Totally agree this disconnect between market cap and pipeline value is insane. Personally, I’m in this one for the long run. A few reasons why I won’t be selling after a short term pop: Peak sales $3–7B in MS alone → if Phase 3 data is positive, that’s a potential multi-billion dollar valuation, not a $75M one. Buyout potential is real. Big pharma (Roche, Novartis, Sanofi, Biogen) all need next-gen MS assets. A successful Phase 3 could mean a $30–100/share takeout, depending on timing. IMU-856 is a hidden card. If the GLP-1 boosting effect gets validated, Immunic isn’t just an MS company anymore. That’s obesity/metabolic upside layered on top. Institutions don’t swing trade. They’re accumulating because they see the late-stage pipeline and M&A optionality. I want to ride the same wave. So yeah, I love the short term thesis you laid out, but for me the real money is in holding through the big catalysts and harvesting when pharma comes knocking.

Mentions:#DD#MS#GLP

Imux: fresh HCW Wainwright deck just dropped. • Management doubling down on Nurr1 biology → positioning vidofludimus calcium as the first true oral neuroprotective MS drug. • CALLIPER PPMS subpopulation signal (33% CDW reduction) highlighted again → setting the stage for late-breaker at ECTRIMS. • Peak sales potential: $3–7B annually in MS alone. At typical pharma multiples, that’s $40–200+/share valuation range if Phase 3 hits. • IMU-856 (GLP-1 booster) still flagged as “further clinical testing in prep” → optionality in obesity/metabolic disease.

Mentions:#MS#CDW#GLP

Imux: fresh HCW Wainwright deck just dropped. Management doubling down on Nurr1 biology → positioning vidofludimus calcium as the first true oral neuroprotective MS drug. CALLIPER PPMS subpopulation signal (33% CDW reduction) highlighted again → setting the stage for late-breaker at ECTRIMS. Peak sales potential: $3–7B annually in MS alone. At typical pharma multiples, that’s $40–200+/share valuation range if Phase 3 hits. IMU-856 (GLP-1 booster) still flagged as “further clinical testing in prep” → optionality in obesity/metabolic disease.

Mentions:#MS#CDW#GLP

Rent a studio apartment and make strange art with MS Paint and post it to reddit every day for years

Mentions:#MS

GS/MS/JPM is corruption.

Mentions:#GS#MS#JPM

GS/MS/JPM make money on the majority companies going public. So when your Canto funds example goes public they have to go through GS/MS/JPM. You say screw it but GS/MS/JPM are at all time highs due to this.

Mentions:#GS#MS#JPM

When the IPO market is hot, the consistent way to play it is through the investment banks and underwriters – Goldman Sachs (GS), Morgan Stanley (MS), JPMorgan (JPM), etc. They earn fees every time they bring a company public, so they’re the real picks-and-shovels of IPO activity. You could also include the exchanges (Nasdaq: NDAQ, NYSE/ICE) since they benefit from listings and higher trading volumes. BX and APO are in a different lane. They can benefit indirectly if their portfolio companies IPO successfully, but that’s lumpy and depends on timing. Their earnings are driven more by fundraising cycles, deal activity, and asset valuations than by whether the IPO calendar is hot in general.

I bought AMD when it was like $1 or so back in the day when all the news sources were saying it was done for. I was reading Ars Technica, and they had conflicting stories or comments from folks. Folks were saying it was done for. But, stories were also coming out that MS and Sony were tapping AMD to create their next-gen console APU's. I knew consoles had a good 5 years life span, so it made no sense to tap AMD for APU's if AMD was going out of business. It did make sense to cut a deal with AMD to get a good deal on APU's, though, as long as AMD would be in business for the next 5 years. So, I bought in. Got like $1000 worth of stock. That was a ton of money for me at the time, b/c I was working a poor job at the time. Then the Ryzen came out, and AMD started taking off. But, I ended up quitting my job and going back to college on student loans. They made me sell off all my assets to get finacial aid, but they didn't say I had to use it to pay for school.. only that I couldn't sit on any money or assets. (they want you to be absolutely broke to get financial aid). So, I cashed it out at $3000, and took my wife on a cruise. I did the math on it later, and I think today the same stock I bought would have been worth $125,000+ or so. But, hey, wife and I had a great cruise. She just graduated college herself, and was working her first job. I was able to pay for her first real vacation from her first real job. Felt good. Don't regret the decision at all.

Mentions:#AMD#MS

Important upcoming events • Phase 2 CALLIPER (progressive MS) study: Top-line data expected in April 2026. • Phase 3 studies ENSURE-1 & ENSURE-2 (relapsing MS): Completion of the studies and publication of top-line data are planned for the end of 2026. Not a good buy now, maybe better February March if it's still there

Mentions:#MS

$AAPL - APPLE TO RAISE IPHONE PRICES FOR FIRST TIME IN 7 YEARS: MS Morgan Stanley expects Apple to modestly increase iPhone 17 prices at its Sept. 9 event, the first hike since 2017. The iPhone 17 Air will debut with a thinner design, C1 modem, and $100 premium over the iPhone 16 Plus, while the Pro will start at $1,099 for 256GB as lower-storage options are dropped. A new 1TB Air will launch at $1,399. MS sees the changes boosting average selling prices 5% in FY26, well above consensus, and does not expect demand to be impacted. The event will also unveil new Apple Watches and AirPods, though no major Apple Intelligence updates are anticipated

Mentions:#AAPL#TIME#MS

#Dont worry he talks like one as well😆 # Benioff was calling MS Co-pilot a total failure and equating it with MS clippy and promoting “agenetic AI” last year. How the tables have turned.

Mentions:#MS

Let’s not forget this is the man who thought Kilmar Garcia literally had the letters and numbers “MS 13” tattooed on his hands because of a photoshopped image showing the letters and numbers “MS 13” superimposed above actual tattoos on his hands

Mentions:#MS

I’d bet money this is for 2 main reasons: 1. Right now some of the only true leverage large blue states have over the federal government is their contributed revenue from income tax. This admin is probably well aware of how many donor blue states like NY, CA, IL, NJ, MN, MA are actually funding the welfare red states who get more money in funding and grants from the feds than they send back in tax revenue (AL, MS, AK, WV, AZ, MT, KY). There’s been chatter recently of the big blue economies discussing withholding such tax payments as protest. This move would effectively kill that leverage and shift to getting the funds in a more indirect way (thru the supply chain). 2. As others have said, this shifts the funding burden of the government almost completely to the bottom 80-90% of earners in the US. Very wealthy people simply do not consume enough per capita to have the tariffs they pay on goods cover even a small fraction of the taxes they currently pay today. People can rebel by not paying their taxes; they cannot as easily stop eating food or buying clothes and necessities. This is another forced tax cut for the wealthy and tax hike for the poor.

Not sure what your definition of "homicide rate" is but Jackson MS currently has a much higher murder rate than those three. Most rankings don't include Jackson as they have a minimum population that excludes places like Jackson. [Jackson homicides over the past 5 years show a trend](https://www.clarionledger.com/story/news/2025/02/16/jackson-homicides-over-the-past-5-years-show-a-trend/77583518007/)

Mentions:#MS

Thanks for your reply. So to answer your questions: a) Definitely, want to be able to "enjoy" 80% of $2M+, vs. not enjoy $1M+. b) I can definitely use my margin for PUTS. I use IBKR for their generous margin policies and rates (transferred everything from ML and MS/e-Trade, when I decided to go Margin, and saw their rates. I'll try a few CSP's, but need to find some stocks I'm familiar with, at prices I'd be comfortable owning at the PUT strike (minus the Premium). c) As for why I'm holding onto COOP (and RKT, for now, once it converts in Q4), is not "just" to save on the tax hit, but TO MAKE MONEY. The "market" has definitely NOT priced the upside of the COOP/RKT deal in the next yr or so, especially with Rate Cuts coming, and lack of full clarity from COOP/RKT on their combined EPS/EBITDA for '26. See: [https://www.tipranks.com/stocks/rkt/forecast#](https://www.tipranks.com/stocks/rkt/forecast#) All these "respected Analysts" haven't updated their forecasts in months, and the \*current\* RKT price is literally (even with a 10% drop in the past weeks, due to some news which I don't feel justifies the drop) is above all their forecasts. MY (and other's who follow the two stocks closely) feel that the combined entity, based on current (non-rate cut) earnings is worth about $25/share, PRE-any rate cut bump in ReFi's etc. ONLY the recent BTIG Rating which I referred earlier has taken this info/number into account. $25 (expected) / $18 (current) RKT price is a \*40% bump for 2026\*, and so I'm not comfortable selling/putting it at risk for getting called, till it hits/gets close to that number (unless it's like at 20% above the current price, with a 30DTE, but I'd need to see what kind of Premium I'd get for that CC). Trust me, my objective is to MAKE MONEY, and leverage the $$ I have on Margin, which is why I setup the layered CC ETF strategy. So far, 1 month in, with about $400k borrowed/invested, post Margin (5.x%), I should be netting around $10K a month. And I'm already planning to "adjust" my layers to shift some $$ away from XDTE to the higher premium Single Stock CC ETFs (that I'm comfortable with, not the highest payers like MSTR focued ones). Would welcome your thoughts/feedback on the above, as I continue to learn how to leverage/grow my $1M+ into $2M+ (and beyond).

If this were true, it would undoubtedly be obfuscated (since Nvidia is banned from selling top end chips to China by the US, and banned from selling H20 chips by China), and if it were obfuscated and Nvidia still knew about it, they would have zero reason to reveal that they're aware of it in their public earnings reports. More likely they're two of the big US-based cloud and/or AI players. (MS/Google/Meta/AWS/xAI)

Mentions:#MS

It’s probably Microsoft and Meta. TBH I wouldn’t worry that much. MS is one customer, sure. But they’re providing GPUs as cloud for various customers so I see it as a bit more diversified.

Mentions:#TBH#MS

Here is my chatgpt: KYTX — Due Diligence Synthesis KYTX is a high-risk / high-reward biotech lottery ticket right now: • It has serious institutional & pharma backing, a strong catalyst calendar, and enough cash to deliver results without near-term financing pressure. • But with no major data yet, it’s all binary bets on 2025–2026 readouts. For a trader, KYTX looks like a catalyst swing stock (buy dips near $3.60–3.70, sell rips into resistance or into catalyst hype). For a long-term speculator, this is a call option on CAR-T in autoimmune — you risk near-total loss if trials flop, but upside is 3–5× if data validates the platform Strengths • Cash runway into 2027 → ~$200M+ cash, debt-free, enough to fund through multiple readouts. • Rich catalyst calendar (late 2025–2026) → MS & RA IITs (Sep/Oct 2025), MG Phase 2 interim (Q4 2025), KYV-102 IND (Q4 2025), SPS registrational topline + BLA (H1 2026). • Strategic partnerships → Gilead, Intellia, Oxford Biomedica, ElevateBio, Verily, Charité → strong external validation + de-risked manufacturing. • Institutional backing → Vida Ventures, Bain, Novo, BlackRock, Vanguard, plus ~10% stake from Gilead → meaningful “smart money” presence. • Potential first-mover advantage → Could become the first CAR-T approved in autoimmune disease (SPS in 2026). ⸻

Here is my chatgpt: KYTX — Due Diligence Synthesis KYTX is a high-risk / high-reward biotech lottery ticket right now: • It has serious institutional & pharma backing, a strong catalyst calendar, and enough cash to deliver results without near-term financing pressure. • But with no major data yet, it’s all binary bets on 2025–2026 readouts. For a trader, KYTX looks like a catalyst swing stock (buy dips near $3.60–3.70, sell rips into resistance or into catalyst hype). For a long-term speculator, this is a call option on CAR-T in autoimmune — you risk near-total loss if trials flop, but upside is 3–5× if data validates the platform Strengths • Cash runway into 2027 → ~$200M+ cash, debt-free, enough to fund through multiple readouts. • Rich catalyst calendar (late 2025–2026) → MS & RA IITs (Sep/Oct 2025), MG Phase 2 interim (Q4 2025), KYV-102 IND (Q4 2025), SPS registrational topline + BLA (H1 2026). • Strategic partnerships → Gilead, Intellia, Oxford Biomedica, ElevateBio, Verily, Charité → strong external validation + de-risked manufacturing. • Institutional backing → Vida Ventures, Bain, Novo, BlackRock, Vanguard, plus ~10% stake from Gilead → meaningful “smart money” presence. • Potential first-mover advantage → Could become the first CAR-T approved in autoimmune disease (SPS in 2026). ⸻ Weaknesses / Risks • No readouts yet → All catalysts are forward-looking; nothing validated clinically at scale. • Rising cash burn → ~$75M in 6M 2025 vs. $49M prior year; raises dilution risk despite runway. • Volatility → Weekly swings >14%, underperforming biotech peers; moves heavily on sentiment. • Execution risk → Scaling CAR-T for autoimmune is unproven compared to oncology. • Insiders not buying → They hold large stakes, but no open-market insider buys in past year (only option grants).

NVDA would reset, but the FCF being spent has to go somewhere. This isn't like the Dotcom boom where shitty companies were being dumped on the public markets. Big tech is printing money and investing it in AI. NVDA obviously benefits and its valuation will reset if/when big tech shifts away, but it won't suddenly turn off the sectors money volcanos. The only way that happens is a recession which has been right around the corner for years. Google TTM EBITA - 139B Meta TTM EBITA - 95B MS TTM EBITA - 162B AAPL TTM EBITA - 141B After the initial fear, the market probably ends up in a better place with less concentration in NVDA.

First off, Gilead is an HIV company first, that's where the money making is. They tried to pivot to oncology under Daniel O' Day with Trodelvy. Before that it was the Kite acquisition for CAR-T. I've worked for both those franchises and also at Genentech where Gilead extensively poached. Gilead does not have the foundation or expertise for the CAR-T therapies offered by KYTX. KYTX is not oncology, it's MS and Myasthenia gravis etc. it's just not an expertise fit. Kite already bought something, my old coworkers there are focused on oncology, not new therapeutic indications

Mentions:#CAR#KYTX#MS

Keep tabs on capex from the big boys like Google, MS, Amazon, xAI, and Meta. When they determine they don't need more datacenter capacity, they won't need more GPUs and Nvidia/TSMC/Broadcom will take a breather. It'll eventually go back to being cyclical and very well expand much more in the future, but at some point this rocket ship will change its trajectory and the market will stop pumping with it. As others have mentioned, there will be software winners and losers, and software winners who then have their lunch eaten. Just like Facebook emerged several years after the dotcom burst, the titans of the 2030s might not even exist yet.

Mentions:#MS

Les boites qui portent le SP500 ne sont pas sous perfusion des VC … Google, Meta, MS n’attendent pas après les VC pour financer leurs IA

Mentions:#VC#MS

>The MIT study published last week shows that 95% of attempted AI implementations at companies fail. Ah the parrotted MIT study. The report fails to clear the bar for any good statistical study. Low n-study with no sampling validity or measurement clarity. There is no data or appendix to reproduce this. Ignoring all this....just because a pilot doesn't progress doesn't mean it isn't delivering any value (would help if study had any measurement clarity). The "study" also attributes the biggest issue is lack of memory and context window. This is something models have been evolving and getting better. > And if you understand the math behind it you'll know that it can be useful as a tool under highly skilled hands of field experts, but that it's not going to be a general "replace all workers" tool like the claims from tech would have you believe. 1. Never claimed it will replace all the workers 2. It doesn't have to be used by highly skilled field experts. Like not even close. A junior programmer with the appropriate model can perform close to a senior programmer (doesn't mean senior programmer doesn't have experience or experience doesn't matter). 3. You are misunderstanding the difference between task and job. 4. Custom models with enough memory and context windows for sector specific are already on the way. These models even assuming they don't replace workers will still be running on GCP, AWS, MS servers. The need for compute will skyrocket and the models will be licensed by companies creating their own models. [AI will be a cash cow for MS,AWS,GCP, ORCL] > I think you forget that the VAST majority of people are just now becoming aware of what big tech does and the younger populace, being much more technically literate, is likely going to see a shift relative to the populace currently. Don't see it at all. Younger people are caring less and less and are pivoting more towards consumerism. Take a look at the TikTok ban - TikTok (chinese company) quite literally is collecting billions of data points and Trump wanted to ban it and the younger generation threw a fit. People are content with the dopamine drip and the algorithm feeding them exactly what they want. > but now there are companies starting with new business models, building the same (and arguably better) services that big tech offers. lol like what? > I think you are severely underestimating the irritation of people that the AI models are trained off of their data, without their permission (sorry burying stuff in the T&Cs might count legally but not to consumers). And all it takes is one lawsuit to completely change the legal framework, or for one law to rewrite what can and cannot be done. Not particularly. Like I mentioned vast majority of people don't even understand. Even if they did they really don't have many options for them to opt out of. Every social media company is collecting information. Your comments are being collected by Reddit and then sent to Google for their models but you are still on here debating an internet stranger. Sure all it take is a law but with how much funding and influence the big tech has? I'll keep my money on big tech and you can keep hoping for reforms that might one day happen. > The models aren't "intelligent" in the human sense. They run statistics on massive datasets and return the most likely set of words based on the input set of words. The human brain, which is the most effective intelligence we know of today, runs on 20W. That's not even enough energy to power the old fashioned tungsten lightbulbs. I do ML. Nobody claimed these models are sentient or intelligent. They don't even need to be "intelligent" - you are confusing AGI with AI. LLMs are just part of ML and we have had ML for years now. It turns out the human brain as special as it is - is still a pattern recognizing statistical machine with a bigger context window and memory. The models don't need to be "intelligent" for them to generate value nor do they need to something special that only humans can do. > It's really best if you learn a little about things, because you seem to be basically building your view based on what you hear from people who have a vested financial interest, not based on independent reviews and a fundamental understanding of the technology. My work literally entails around DE/ML. I work with these models regularly. I don't think you quite understand the nuances of AI...you keep saying "math" but I don't see any actual evidence for your statements or your so called math.

> AI isn't a cash cow now but it definitely will be down the line What about AI makes you think this? The MIT study published last week shows that 95% of attempted AI implementations at companies fail. And if you understand the math behind it you'll know that it can be useful as a tool under highly skilled hands of field experts, but that it's not going to be a general "replace all workers" tool like the claims from tech would have you believe. > the VAST majority of consumers simply don't care enough to request their data to be deleted or corrected. I think you forget that the VAST majority of people are *just now* becoming aware of what big tech does and the younger populace, being much more technically literate, is likely going to see a shift relative to the populace currently. Because let's be realistic, the populace over ~40 is not technically literate in any broad enough numbers. Factor in that big tech got a lead by monopolizing things and making tech "smooth" (although I wouldn't call most of windows/MS/Apple/Google products smooth, I'd call them isolated environments), but now there are companies starting with new business models, building the same (and arguably better) services that big tech offers. > Eh there is always a growing backlash against big tech doesn't mean shit. Big tech is raking in record profits and essentially monopolizing AI. Only a handful of companies can afford to be in the AI race. The public can cry and scream all they want. I think you are severely underestimating the irritation of people that the AI models are trained off of their data, without their permission (sorry burying stuff in the T&Cs might count legally but not to consumers). And all it takes is one lawsuit to completely change the legal framework, or for one law to rewrite what can and cannot be done. And to my previous comment that you should really understand the math behind the models, of course big tech is the only one who can afford to do it. The models aren't "intelligent" in the human sense. They run statistics on massive datasets and return the most likely set of words based on the input set of words. The human brain, which is the most effective intelligence we know of today, runs on 20W. That's not even enough energy to power the old fashioned tungsten lightbulbs. When big tech sees the same output the models currently do, while only needing a few dozen watts of power to train and run (instead of a small to medium power plants worth of energy output), *then* I might believe the hype. But even then, without changes to the algorithms, it's just a statistical model, so it won't do anything that special compared to the human brain. It's really best if you learn a little about things, because you seem to be basically building your view based on what you hear from people who have a vested financial interest, not based on independent reviews and a fundamental understanding of the technology.

Mentions:#MS

Why don't you take a look at St. Louis, Fort Dallas, Jackson, MS, etc. Per capris those cities are far worse than Chicago. This is all a distraction from the Epstein files. Trump and Republicans are protecting pedos!

Mentions:#MS

They pivoted to Azure and had an inbuilt customer base from their enterprise business. Consumer was never what MS was about, it was always corporate and they are still dominant AF in that space.

Mentions:#MS

Gamers hate Bobby Kotick with a white hot passion, but he sold Activision Blizzard at its absolute peak. Microsoft left holding the bag.  Gamers think franchises like WoW or OW are greedy now, wait into people at MS HQ run the math on how much they need to charge on cash store items to make back what they paid for Activision Blizzard.

Mentions:#MS

MS, Bytedance,tencent,Meta, Tesla/xai Amazon and Google.

Mentions:#MS

MS-13 members are bullish on Morgan Stanley 

Mentions:#MS

I have MS. Advancement here would look like: - something that rapidly allows remyelination. But existing scar tissue would prevent this for existing damage - something that allows repair of damaged axons, particularly in the spine.

Mentions:#MS

Cool a Nervgen post I love this drug’s potential for MS patients especially.

Mentions:#MS

I have an MS in Quantitative Economics from NYU. I completely agree with their comment. Imo, people who attack statements without providing any counterpoint are the ones who do not contribute to the conversation. In this case, that was you, mate.

Mentions:#MS

im working in the field and dont see them that much as a competition anymore. MS will eat them with bundling automation & agents into everything an enterprise uses.

Mentions:#MS

No, I’m not on the spectrum. I’m just an extremely analytical person that’s worked in investment management and corporate finance for my whole career. I have great respect for the field of psychology when it’s helpful and professionals are factual and open-minded. Your comment about me having a hatred of politics is incorrect. I find politics fascinating. What area do you specialize in and education - LCSW, BS, MS, PsyD, PhD?

Mentions:#MS
r/stocksSee Comment

ASTS and NGENF (curing spinal cord injury, hearing loss, MS, anything related to nerve damage) and phase 2 trials successful.

Holy fuck I am so glad I work at MS and not Intel anymore

Mentions:#MS

New Cracker Barrel logo was designed in MS Paint

Mentions:#MS

> A single model can process more text in a minute than a human could read in a lifetime, and it can do it for millions of users simultaneously. What you are talking about here is "computers" not AI. Using AI to do it you're going to get inaccuracies, which matter at scale as you kill people by say, processing 10m patient records with 99.9% accuracy in a non-deterministic way, concluding that a certain medication should no longer be covered by a health plan, and then killing 10k people when they are cut off. But you can do that sort of thing accurately in a deterministic way, if only you could use the _computing power_ underlying the AI. Right now we're at this phase where we're struggling to find _some kind of method_, by God if only it existed, to tell an AI _exactly_ what we want to do with data. We will, one day, get to the point where everyone realizes that such a method is called a _programming language_ and does not involve AI of any kind. > Or maybe all the Reddit bros are right! ChatGPT5 sucks ass and has exposed the smartest entrepreneurs on the planet cuz they're actually big dumb idiots wasting their trillions of dollars. Christ almighty, SV is littered with failures. Google, MS, and Meta themselves have repeatedly failed big-budget moves to expand. Metaverse is dead, and no you cannot tell me selling one million Raybans with cameras in them "the Metaverse." They just burned that cash.

Mentions:#MS

Morningstar Premium, by far. It's better with mutual funds than stocks, but does a great job on both. I self-manage about 25 holdings (1/3 of nw). Every idea I see in an article or TV or whatever has to pass the MS test (four or five stars). I have enough in MFs at T. Rowe Price that I get it free, but I'd pay if I didn't.

Mentions:#MS

Have you got a link? I can’t find the MS statement

Mentions:#MS

Post was based on $150. MS for most. UBS for others

Mentions:#MS#UBS

That was my thought... with Google Meets being available for free and MS Teams being included with MS Office... what company would pay extra to use Zoom? Seems like they're going to get pushed out by Goog and MSFT... I have 8/29 puts.

Mentions:#MS#MSFT

lol, if AI is really that good the pilot failure rate wouldn’t be that high. Stop finding excuses. When MS Office was released, did companies pilot it and only 5% succeeded? No, most companies just buy and use the software. When personal computing become popular did companies say let’s do a pilot? No, companies just buy computers and use.

Mentions:#MS

*MS was not a politician.*

Mentions:#MS

I use Foundry and it’s literally MS Office for cool shit. PLTR 250 EOY

Mentions:#MS#PLTR

I use Foundry and it’s literally MS Office for cool shit. 1T EOY 2026.

Mentions:#MS

MS wasn’t a dot com poster child in the 2000s

Mentions:#MS
r/stocksSee Comment

>AI will not be used to significantly improve what makes them real money, FB and Instagram How can you possibly know this? Most innovations are only obvious in hindsight. We're literally in the MS-DOS/dial-up era of AI, when command line was the primary interface and images took a minute or more to load. It's like saying internet potential was basically maxxed out during Prodigy.

Mentions:#MS

Yeah internal analytics and optimizations are fine but that's not the type of money they have been spending. They have been throwing billions in search of SSI and AGI. >there are many ai tools that would be perfect for social media music making video generation perfect tools to edit videos with. There already are MANY tools that leverage this. Lot of competitors in this space and the juice isn't worth the squeeze. Even assuming they have great models where will they run? The bulk of the money will go to AWS, GCP, and MS.

Mentions:#AGI#MS

I don't think people are bearing on AI but are more bearish on meta's LT vision. FB is absolutely massive and their foundation but after that? They acquired whatsapp and instagram. They burned through billions on metaverse which so far has been lackluster. Their AI initiative just seems desperate with no clear vision or progress. They are desperately throwing money to get talent which just looks not promising from the outside. Personally their AI models are good but Meta doesn't have the same distribution as Google and Microsoft does so how will they actually generate revenue from AI (outside of internal analytics). Google has cloud, android, search, and their suite. MS has their cloud. AWS has their cloud. Meta has apps and they also don't have the infrastructure or compute.

Mentions:#MS

If you can get the real JPM advisors and real MS advisors, the private wealth division, those guys are solid. Usually that 10m minimum. Otherwise use the boutique firms with big custodians who have a niche. I have a friend who is a CPA by trade but also a FA, he has a really good value add to his clients. My firm works really well in the private market space (think open ai, anduril etc) and with business founders. I have certs for helping people exit their business tax efficiently, for example.

Mentions:#JPM#MS#FA

Actually you‘re supposed to censor everything, and once it‘s all black just draw a line going up with MS paint and then you‘re good to go

Mentions:#MS

No, it is essentially that simple. Inflation roughly measures the costs of things that people need, regardless of whether they work in a shoe or pant factory. You're correct that sectors can be affected differently, but on average, people experience inflation the same. So, if you work in a shoe factory, and your employer can't give you a raise that matches inflation, you should quit and go work in the pants factory. But, what would I know; my MS is in Quantitative Economics, not Inflation Economics.

Mentions:#MS

MSNBC going to rename to MS Now 🤢 Then in 6 months they'll rename to just Now.

Mentions:#MS

When's the last time you used Linux? It's come a long way in the last decade. For regular consumers, and businesses that want to use MS office on desktop, I don't think it's as easy to use. For development work, and AI tools, it's a strong alternative. I personally wouldn't want to do dev work on anything but Linux, but like Windows better for my office job.

Mentions:#MS

https://www.cnbc.com/quotes/10Y3MS Sorry to say your calls are probably fucked.

Mentions:#MS

https://www.cnbc.com/quotes/10Y3MS Your calls are f u c k e d.

Mentions:#MS

I'm not so sure. Objectively speaking, we've come a long way with LLM chat and image generation in a short time. They are disrupting career fields and artists. Eventually the VC funding runs out, but all the biggest players in the space are either subsidiaries of giants that can take the hit, or else aligned to roll into them eventually anyway. And big players like MS/Meta/Alphabet are much more broadly invested in machine learning in general. If the LLM approach falls apart, it will still be cleverly written off and hidden behind new shiny things. If Meta can spend billions every quarter on the Metaverse and not pop a bubble, the current AI boom isn't going to hard crash anything. LLM is a buzzword, one that major players keep using to describe all sorts of ML and non-ML products. It can't fail if the public doesn't even recognize what it actually is.

Mentions:#VC#MS#ML

Currently looking at Prof Amato and any affiliation with IMUX. She seems to be strong proponent of MS progression treatment (indication for 838) and will be speaking at ECTRIMS in Sep. (https://pag.virtual-meeting.org/congrex/ectrims2025/en-GB/pag/presentation/375467) ECTRIMS is the largest MS conference in EU. Perhaps institutions are positioning for data/updates from IMUX? No confirmation but highly likely IMUX will present there given past presentations at high profile conferences. Still researching

Mentions:#IMUX#MS#EU

I will check that out this weekend. My strengths are more on the pharma side vs financial. Especially in the MS space. My conviction is strong on the science, less so on how the company handles the financial end of getting this through approval.

Mentions:#MS

Is it the end of the world? What haffen to MS? 💃💃💃🤣

Mentions:#MS

It is interesting to see all the calls of communism and bailing out of failing company, when Intel \*is\* one of those companies, similar to Boeing, which holds significant national interest. Some companies will indeed be too big to fall. Yeah, both companies had some bad fumbles, but imo Intel's overall direction has been agreeable/they aren't playing as "dirty" as Boeing: Gelsinger's bet on fabs has the right idea, just that at the end of the day, it is very difficult to compete at the highest levels. Had 18A/14A been more successful, INTC might be at like $80 and not $20. Having their own fabrication capabilities will be key to Intel's survival in the upcoming decade: especially since x86 is losing its grip as ARM and other RISC designs become more main stream. We see that in Apple silicon, we see that in MS' reignition of Windows on ARM, we see it with Graviton, etc. The whole resting on laurels happened before Gelsinger's time. Hardware enthusiasts will be glad that Intel continues to survive so the world is not reliant on TSMC, where companies are outbidding each other on the latest and greatest capacities.

Mentions:#INTC#ARM#MS

OpenAI is not profitable at all, wtf are you talking about? Meta, Google or MS may be profitable overall, but not their AI divisions, those are huge money sinks. There's also a definite ceiling for AI potential: the finite resources for computation (especially training), and (arguably more important) finite training data.

Mentions:#MS

Trial closure mid 2026 but data not project to be public until 12/26. 3-4 months for internal planning and then FDA submission so no commercial activity likely until early 2028. Great DD YOLO4lyfe18. Runway projected 7.2 months after recent offerings so they will need raise. Given previous split in 2019, path of least resistance is another reverse split. Vivid spot on with conference activity. I think they are def looking for a buyer to avoid RS (considering some insider buying this year). I don't see any significant catalyst until end of 2026. Trying to figure out if I wait for RS and buy once price drops from split or load up slowly over he next couple of quarters. I've been crushed by RS before and it's not pleasant. Key drivers are MS progression endpoint , not ARR like every other MS drug but if they win on hepatotoxicity, this will gain traction quickly with Docs if teh get NDA approval.

Mentions:#DD#RS#MS#ARR

CRWV - just sat through the whole earnings conference call. Super impressive - looks like these guys will take over SMCI and DELL business over the next few years. Their customers are: Google, MS/OpenAI, Meta, NVDA - just name it.... reminds me of PLTR....

***BREAKING: “Commissioner’s citizenship status under federal investigation after suspicious MS13 tattoos discovered”***

Mentions:#MS

> Now do the epstein files [Too busy taking over DC because of crime, even though they are at a 30-year low.](https://www.justice.gov/usao-dc/pr/violent-crime-dc-hits-30-year-low) He should peep the crime stats outta AL, LA, TX and MS... but I digress.

Mentions:#DC#AL#MS

Copy pasting my other comment here: https://futurism.com/microsoft-ceo-ai-generating-no-value Not sure man, it seems like the consensus in MS is “we are losing a lot of money on AI but it’s fine because we and the investors think it will generate a lot of profit in future” Which does sound awfully similar to dotcom bubble.

Mentions:#MS

https://futurism.com/microsoft-ceo-ai-generating-no-value Not sure man, it seems like the consensus in MS is “we are losing a lot of money on AI but it’s fine because we and the investors think it will generate a lot of profit in future” Which does sound awfully similar to dotcom bubble.

Mentions:#MS

Over the past few weeks, Immunic (IMUX) has quietly been stacking up positive developments: • Data strength vs. big pharma: Vidofludimus calcium (IMU-838) has shown results in MS that compare favorably — and in some ways exceed — those from Roche’s rival drug in similar patient populations. • New scientific angles: Recent peer-reviewed publications point to potential expansion into other autoimmune diseases, including type 1 diabetes, by boosting regulatory T cells (Tregs) while reducing harmful immune activation. • Institutional confidence building: Aberdeen disclosed an 8.6% stake and now 683 Capital Management has filed owning 9.9%. That’s two sizable institutional holders entering within weeks of each other. • Insider alignment: There was insider buying in June, signaling management’s own confidence in the company’s trajectory. • Pipeline quietly expanding: A new U.S. patent filing for deuterated RORγ inverse agonists adds another potential long-term value driver beyond IMU-838. Yes, the market hasn’t woken up yet — the share price is still hugging the $1 zone — but the ingredients for a serious re-rating are coming together: strong data, expanding IP, insider alignment, and heavyweight institutions building positions before major catalysts hit.

Mentions:#IMUX#MS#IP
r/stocksSee Comment

JPM and MS have both downgraded in the past month and have low 40s targets. Trusting an outlier analyst is a quick way to go broke.

Mentions:#JPM#MS
r/stocksSee Comment

I live in Madison, MS. Every truck I see on the road is a top tier Denali trim or King ranch or some crap. Some of these trucks are worth more than houses where I grew up. Sometimes I wonder where these people have so much money for these vehicles. The average home price is 500k and they go way up from there. Everyone’s kids are in private school. I took my kid to LULU and got 2 pairs of yoga pants and a shirt, walked out with almost $400 bill. Lady behind me was buying 10 times that amount of clothing for 3 kids. So yea economy is booming. Also I have family in TX, OK, and FL that I visit frequently. It’s the same scene at their places as well. I will admit I’ve never visited some of the ran down cities you spoke of.

Mentions:#MS#LULU#FL

That's actually a good thing, man. We need more research on the compounds. I'm an MS patient who smokes to alleviate nerve symptoms. It's not the THC or CBD, there's something unique to full flower that really helps turn off MS tingles. But we don't know which one yet...so I stay fucking blasted so I don't feel pain. I'd rather have less brain fog with my treatment.

Mentions:#MS#THC
r/stocksSee Comment

Because no enterprises are using GSuite, so they transition to what their work is using. Before FIRE'ing I was at Oracle and before that Groupon, everyone uses MS 365. Also at Oracle my division was integrated with hospital IT, all hospitals use 365, obviously not for HIPAA related things as that has its own EMR app but for collaboration its 365. I used GSuite now in my personal life as I'm not paying for 365 and for email I use ProtonMail.

Mentions:#MS#EMR

Figma? Ah, the collaborative design tool that's been printing money faster than a meme stock pump. Founded in 2012 by Brown University CS nerds Dylan Field and Evan Wallace, it started as a browser-based graphics editor but evolved into the go-to platform for UI/UX pros—think real-time collab, prototyping, and now AI wizardry like Figma Make for auto-generating designs from prompts, plus features like Code Layers and natural language prototyping. On the biz side, it's a beast: Post-IPO last week (yeah, we're in 2025), shares skyrocketed 250% on day one, valuing it in the stratosphere amid the AI hype. Revenue's booming from cloud-native tools that ditch desktop clunkers like Adobe XD. Latest updates from Config 2025 include Figma Sites (beta for publishing designs to web) and Liquid Glass for slicker interfaces. If you're betting on it in WSB style, it's dominating a $70B design market with AI edges that make competitors look like MS Paint.

Mentions:#UX#MS
r/stocksSee Comment

Google docs imo is still the go to for live collab. Want to brainstorm some stuff during a meeting? Just make a doc and share that, no need to move it onto onedrive, then open it with the web version of words. Even stuff like budgeting: just have an online spreadsheet and tweak the numbers live during a meeting. being able to just type [docs.new](http://docs.new) into the browser for a new document or [sheets.new](http://sheets.new) for a new sheet is a major gamechanger that MS still struggle with. For large scale/serious things, word and excel is still the way to go. Though being able to just write js scripts into google sheets instead of basic is nice...

Mentions:#MS

Me too. I went so far as to read MS treatment boards where they discussed the effects of switching to brumvi vs prior treatments or not wanting to switch, whatever, just chatting about treatment options. It seemed like aside from being new, it was a clear better alternative on the ground. Also honestly MS is so scary. Right up there with Alzheimer’s for me. That’s what I get for fooling around in biomeds.

Mentions:#MS

PHGE nice reaction despite MS exits

Mentions:#PHGE#MS

RDDT used to do it months ago (been a while since i traded it), nvidia has a bunch. KSS and MS did it today. SPY always does this to the point where it made me quit buying 0 DTE bc of taking Ls due to this pattern.

r/stocksSee Comment

Retail vs Institutions: who is buying and who is selling? Easy! Just review the following predictions by two Wall Street giants: (1) On 11 July 2025, GS predicted S&P500 will rise to 6,900 in twelve months time (2) 1-2 weeks later, Mike Wilson of MS out-did his GS peer: Mike predicted S&P500 will rise to 7,200 by mid-2026 Conclusion: Given above predictions, Retail has been buying, so as to provide exit liquidity for the much-valued institutional clients of GS and MS.

Mentions:#GS#MS

Rumor is the mother of "Big Balls" will join 4:30pm presser to announce Illegal MS-13 gang member slapped her son yesterday.

Mentions:#MS

Now AAPL announced $100 bil investment - watch AI players. MS, OpenAI and CRWV will announce $100 bil investment in AI - they’re  already close to that number….

Mentions:#AAPL#MS

Earnings are later this week after the MS stock acquisition. That plus traction and the vote of confidence from Morgan Stanley basically

Mentions:#MS

Answered in a reply below. Dual math/CS undergrad, MS computational statistics (quant finance).

Mentions:#MS

Is that true?  MS owns half?  How long until that's all paid back?

Mentions:#MS

I use the clickbait articles that fit my interests - E.g., anything mentioning dividend, I'll look up those tickers on Morningstar to see if they're worth considering. Or anything FIRE related. Or "best states to retire" type lists. I make trades based on the MS ratings, but get new ideas from articles. I've outsourced the reading filings and studying fundamentals to Morningstar, well worth the cost of Premium (tho I don't pay it as we get it free from T. Rowe Price). But I read every one with an eye toward what that source is getting out of my doing so.

Mentions:#MS
r/stocksSee Comment

That's a valid opinion, and we'll see. I do think no one is going to see their ads, if no one uses their products. And people aren't going to user their products if they fundamentally don't trust the company. The kind of trust ruined by depending on a product only to have it yanked. Again, the reason their cloud console failed, which they openly admitted. So what did they then do? Killed it prematurely. A product that required people to *purchase actual hardware*. Most other products are similarly not low-investment trivial things, even if "free". When you try to get people to use your social media network for example, that requires a significant investment and risk on the part of millions of users. Pull that rug, and you absolutely torch trust. Or a proprietary messaging platform. Or an office collaboration platform. Or in the case of Picasa for example, Christ they could have just not bought the fucking thing, and it would absolutely still exist. It was fucking amazing. I *still* use the last version on Linux under Wine to manage many TBs of photos, even though it's increasingly becoming broken. But no, Google had to buy it, then kill it. Then every year they inexplicably remove more and more features from "Google Photos" - to the point where it's utterly unusable now, essentially killed. I used to love Google. I used to aspire to work for them. (A former MS employee.) But now, fuck them. I have spent dozens - possibly hundreds - of hours de-googling my life, because I couldn't tolerate the very real and proven risk of them canceling many of the many things I hand come to rely on. Throwing spaghetti on the wall to see what sticks, worked when they were young and lean. Trust me, it was part of my job to understand that business model when I worked at Microsoft, which at one point spun off an entire org to imitate it. And just parroting the talking point that "Google is an advertising company", even though they themselves have said it through various mouthpieces, is profoundly short-sighted, and I believe sometimes even a purposeful red-herring at times. Last year, some 10% of Alphabet net profit came from cloud computing. AI will continue driving revenue, and not just on google search results but in actual subscription products. Advertising still accounts for 74% of net profit, but huge bets like Waymo are some of their biggest investments but with negative revenue. It's easy to say that Search is simply an "ad platform", but ignores how hard search is. You could say the same thing about Youtube, but also ignores the challenges of adding 4.3 Petabytes of data every day. The cowboy approach of Google's early days doesn't work when you are one of the largest corporations underpinning the global economy. There's a reason you don't see Apple or Microsoft doing that anymore. They have far more consumer trust. Yes they still innovate - but generally only on large capital projects that small startups can't do, but have already proven to be relatively safer bets. (VR and AR projects being notably - and surprisingly IMO - bad bets by everyone.) TLDR: Fuck Google. But IMO they are absolutely fucking themselves, and will be as irrelevant as Yahoo in ten or twenty years.

Mentions:#MS
r/stocksSee Comment

Azure is highly inefficient compared to AWS and G cloud. But MS also has a portfolio of other highly profitable products that earn so much more profit per product then other two companies. They also use Unlimited companies to withdraw money from customers. Unlimited companies are not obligated to publicly report profits.

Mentions:#MS

The fact that so many fintech firms (COIN, MS) cannot produce an android app that works in landscape mode on a tablet is frankly disturbing.

Mentions:#COIN#MS

The middle east peace deal was signed during trumps admin, he even campaigned on it as a win that he brought peace to middle east. Also what is this many asians stuff, name the countries, also there is more than just Japan and China. Also how did USAID topple these countries? You dont even list them. Also it was your dumbass president who was claiming MS16 and other drug cartels as being more dangerous than the taliban and other terrorist organizations, so your issue is with Trump on that issue. Also the only people making anyone a saint is republicans making trump a pedophile Jesus

Mentions:#MS

What in the in actual fuck is this? No numbers, no positions. And it looks like you used MS Paint to add that darker green line in there for the win. BOT or Regarded...either way read the damn community rules before posting on here. Sick of looking at this garbage. Hope you get banned! You get the Wendeeez nuts for this! https://preview.redd.it/li1bfob7f1hf1.jpeg?width=1179&format=pjpg&auto=webp&s=23c0186e29a30b88c580e9a110630076ce058f34

Mentions:#MS

Do you really think the likes of JPM,MS Goldman and Blackrock don't have their own data collection depts?

Mentions:#JPM#MS